We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
93 hedge funds and large institutions have $64.9M invested in Invesco Pharmaceuticals ETF in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.13% more ownership
Funds ownership: 23% → 24.13% (+1.1%)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
2% less capital invested
Capital invested by funds: $66M → $64.9M (-$1.1M)
4% less funds holding
Funds holding: 97 → 93 (-4)
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
Holders
93
Holders Change
-4
Holders Change %
-4.12%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
18
Reduced
24
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$4.51M |
| 2 |
Goldman Sachs
New York
|
+$2.75M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$790K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$697K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$508K |
Top Sellers
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$2.41M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.19M |
| 3 |
Jane Street
New York
|
-$1.16M |
| 4 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
-$812K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$680K |
